Urinary tubular biomarkers as predictors of death in critically ill patients with COVID-19

Biomark Med. 2022 Jun;16(9):681-692. doi: 10.2217/bmm-2021-0631. Epub 2022 May 9.

Abstract

Aim: To evaluate the prediction capacity of urinary biomarkers for death in critically ill patients with COVID-19. Methods: This is a prospective study with critically ill patients due to COVID-19 infection. The urinary biomarkers NGAL, KIM-1, MCP-1 and nephrin were quantified on ICU admission. Results: There was 40% of death. Urinary nephrin and MCP-1 had no association with death. Tubular biomarkers (proteinuria, NGAL and KIM-1) were predictors of death and cut-off values of them for death were useful in stratify patients with worse prognosis. In a multivariate cox regression analysis, only NGAL remains associated with a two-mount survival chance. Conclusion: Kidney tubular biomarkers, mostly urinary NGAL, had useful capacity to predict death in critically ill COVID-19 patients.

Keywords: COVID-19; NGAL; death; kidney biomarkers.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Kidney Injury* / diagnosis
  • Biomarkers
  • COVID-19*
  • Critical Illness
  • Hepatitis A Virus Cellular Receptor 1
  • Humans
  • Lipocalin-2
  • Prospective Studies

Substances

  • Biomarkers
  • Hepatitis A Virus Cellular Receptor 1
  • Lipocalin-2